{"url_path":"/sec/modd/10-k/2026/item-9a","section_key":"item-9a","section_title":"Item 9A CONTROLS AND PROCEDURES","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1074871/0001213900-26-073223-index.html","accession_number":"0001213900-26-073223","cik":"0001074871","ticker":"MODD","issuer_name":"Modular Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1074871/0001213900-26-073223-index.html","primary_entity_key":"0001074871","primary_entity_name":"Modular Medical, Inc."},"word_count":925,"has_tables":true,"body_markdown":"ITEM\n9A. CONTROLS AND PROCEDURES\n\n \n\n*Evaluation\nof Disclosure Controls and Procedures*\n\n \n\nDisclosure\ncontrols and procedures are designed to ensure that information required to be disclosed in the reports filed with or furnished to the\nSecurities and Exchange Commission, or the SEC, under the Securities Exchange Act of 1934, as amended (the “Exchange Act”),\nis recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls\nand procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the\nreports filed under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief\nfinancial officer, to allow timely decisions regarding required disclosure.\n\n \n\nUnder the supervision and with the participation of our management,\nincluding our chief executive officer and our chief financial officer, we conducted an evaluation of the effectiveness of the design and\noperation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this\nevaluation, our management concluded that as of March 31, 2026, our disclosure controls and procedures were effective.\n\n \n\n*Management’s\nAnnual Report on Internal Control over Financial Reporting*\n\n \n\nOur\nmanagement is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined\nin Rules 13a-15(f) and 15d-15(f) under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management\nrecognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving\nthe desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship\nof possible controls. Internal control over financial reporting is the process designed by, or under the supervision of, our chief executive\nofficer and chief financial officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance\nregarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance\nwith generally accepted accounting principles, and includes those policies and procedures that: (i) pertain to the maintenance of records\nthat in reasonable detail accurately and fairly reflect our transactions and dispositions of assets; (ii) provide reasonable assurance\nthat transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted\naccounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management\nand directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition\nof our assets that could have a material effect on the financial statements.\n\n \n\n46 \n\n \n\n \n\nUnder the supervision and with the participation of our management,\nincluding our chief executive officer and chief financial officer, we conducted an assessment of the effectiveness of our internal control\nover financial reporting as of the end of the period covered by this Annual Report on Form 10-K. In making this assessment, we used the\ncriteria based on the framework in Internal Control—Integrated Framework (2013 Framework) issued by the Committee of Sponsoring\nOrganizations of the Treadway Commission. Based on the assessment, our management concluded that our internal control over financial reporting\nwas effective as of March 31, 2026.\n\n \n\n*Remediation of a Previously Reported Material\nWeakness in Internal Control Over Financial Reporting*\n\n \n\nAs previously reported\nin our Form 10-Q for the period ended December 31, 2025, we identified a material weaknesses in our internal control over financial reporting.\nWe did not design and maintain effective controls related to the accounting for the warrants issued in the public offering completed\nin December 2025. In response to this identified material weakness, our management, with the oversight of the Audit Committee of our\nboard of directors, has been actively engaged in remediating the above material\nweakness. During the quarter ended March 31, 2026, we implemented remediation measures designed to remediate this material weakness,\nincluding:\n\n \n\n●Engaging\nexternal technical accounting specialists to assist management in evaluating the accounting\nfor financing transactions involving warrants and similar financial instruments; and\n\n \n\n●Designing\nand implementing formal review and approval controls over management’s accounting analyses\nfor such transactions, to be performed by personnel with the appropriate level of technical\naccounting knowledge, experience and training.\n\n  \n\nManagement has concluded that the remediation measures described above\nrelated to the accounting for warrants, and similar financial instruments have been implemented, and operated\neffectively for a sufficient period of time for management to conclude, based on the results of our testing over the design and operating\neffectiveness of these controls, that the previously identified material weakness has been remediated as of March 31, 2026.\n\n \n\n*Changes\nin Internal Control over Financial Reporting*\n\n \n\nExcept for the\nremediation measures described above, there were no\nadditional changes in our internal controls over financial reporting during the fourth fiscal quarter of 2026 that have materially\naffected, or are reasonably likely to materially affect, our internal control over financial reporting.\n\n \n\n*Limitations on Effectiveness of Controls and\nProcedures*\n\n \n\nBecause of its inherent limitations, cost-effective\ninternal controls over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed,\nhave inherent limitations, including the possibility of human error and the circumvention of overriding controls. Accordingly, even effective\ninternal control over financial reporting can provide only reasonable assurance with respect to consolidated financial statement preparation.\nAlso, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because\nof changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate."}